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Abstract
Background: Vitamin A deficiency (VAD) is known to be a major public health problem among women of
reproductive age in South East Asia and Africa. In Ethiopia, there are no studies conducted on serum vitamin A
status of HIV-infected pregnant women. Therefore, the present study was aimed at determining the level of serum
vitamin A and VAD among pregnant women with and without HIV infection in tropical settings of Northwest
Ethiopia.
Methods: In this cross-sectional study, blood samples were collected from 423 pregnant women and from 55
healthy volunteers who visited the University of Gondar Hospital. Serum concentration of vitamin A was measured
by high performance liquid chromatography.
Results: After controlling for total serum protein, albumin and demographic variables, the mean ± SD serum
vitamin A in HIV seropositive pregnant women (0.96 ± 0.42 μmol/L) was significantly lower than that in pregnant
women without HIV infection (1.10 ± 0.45 μmol/L, P < 0.05). Likewise, the level of serum vitamin A in HIV
seropositive non-pregnant women (0.74 ± 0.39) was significantly lower than that in HIV negative non-pregnant
women (1.18 ± 0.59 μmol/L, P < 0.004). VAD (serum retinol < 0.7 μmol/L) was observed in 18.4% and 17.7% of HIV
infected and uninfected pregnant women, respectively. Forty six percent of non-pregnant women with HIV
infection had VAD while only 28% controls were deficient for vitamin A (P = 0.002).
Conclusion: The present study shows that VAD is a major public health problem among pregnant women in the
tropical settings of Northwest Ethiopia. Considering the possible implications of VAD during pregnancy, we
recommend multivitamin (which has a lower level of vitamin A) supplementation in the care and management of
pregnant women with or without HIV infection.
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Background
Vitamin A deficiency (VAD) is known to be a significant
public health problem around the world and it is parti-
cularly serious among women of reproductive age in
South-East Asia and Africa [1-4]. It has now become
evident that VAD in women has negative consequences
on their health status as well as on their infants [3,4].
The link between VAD morbidity and mortality from
infectious diseases [5] and non-infectious diseases [6-8]
has been known for several years.
VAD in pregnant women is associated with night
blindness, severe anaemia, wasting, malnutrition, and
reproductive and infectious morbidity [9], and increased
risk of mortality 1-2 years following delivery [4]. VAD
reduces lymphocyte response [10], and also leads to
reduced levels of secretory IgA in mucous membranes
and therefore weakens the local barriers to infection
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any medium, provided the original work is properly cited.[7,11,12]. As a result, vitamin A deficient women were
found to be more susceptible to illnesses of both infec-
tious such as frequent infection of mucous surface of
hallow viscera [4] and non-infectious (eclampsia, pre-
eclampsia, premature rupture of membrane) diseases
[6,13,14].
In the era of HIV/AIDS, vitamin A was also postu-
lated to reduce mother to child transmission (MTCT) of
HIV by affecting several maternal, fetal, and/or child
risk factors for transmission, including the clinical,
immunological, or viral stage of HIV disease among
pregnant women. Vitamin A has an effect on the integ-
rity of the epithelial lining of the placenta, maternal
lower genital tract, or breast. Its deficiency leads to the
occurrence of prematurity and low birth weight, and the
status of the systemic and digestive mucosal immune
systems of the fetus and the child [15,16]. Observational
studies in sub-Saharan Africa have shown that, low
serum vitamin A levels in HIV-infected women to be
associated with significantly increased rates of MTCT of
HIV [17,18] and infant mortality [17,19]. On the con-
trary, randomized trials of vitamin A supplementation
have found that, vitamin A supplementation increases
the risk of MTCT [20,21] and can increase mortality in
some children born to HIV positive mothers. Vitamin A
supplementation in HIV-infected children, on the other
hand, has been associated with protective effects against
mortality and morbidity, sim i l a rt ot h a ts e e ni nH I V -
negative children [22].
In Ethiopia, studies on VAD in the general population
and among pregnant women are scant, despite decades
of documentation of VAD as a major public health pro-
blem affecting up to 40% of pregnant women [23-25].
Recently, VAD has also been reported as a severe public
health problem among tuberculosis [26] and diarrheic
[27] patients infected with HIV. There are no studies
examining serum vitamin A status of HIV-infected preg-
nant women in northwest Ethiopia. Therefore, the pre-
sent study aimed to determine the level of serum
vitamin A among pregnant women with and without
HIV infection in tropical settings of Northwest Ethiopia.
Methods
Subjects and settings
Pregnant women who visited the antenatal clinic of the
University of Gondar Hospital between March and June
2005 in their first trimester for routine antenatal care
follow-ups were approached for recruitment. The Hospi-
tal is a tertiary level teaching and service rendering hos-
pital that provides health service for over 5 million
inhabitants in Northwest Ethiopia. Healthy non preg-
nant women, who were living in the same geographic
locale as pregnant participants, were recruited from
voluntary blood donors and served as control subjects.
Informed consent was obtained from the study partici-
pants and approved by the Research Ethics Committee
of the University of Gondar. None of the subjects had
cirrhosis and none of them received vitamin A
supplementation.
Anthropometric data
Body weight and height was measured to the nearest 0.1
kg on an electronic digital scale and to the nearest 0.1
cm, respectively. Body mass index (BMI) was calculated
and used to determine the nutritional status of the
study subjects [28], though it is not a surrogate for
nutritional assessment during pregnancy.
Blood collection and HIV screening
About 5 ml of venous blood was collected from each
subject as per the routine antenatal care follow up of
the pregnant women in the morning but fasting status
was not ascertained. After clot was retracted, the blood
samples were centrifuged and sera were separated from
the cells following standard procedures and stored at
-40°C until tested. The sera were tested for presence of
HIV-1 antibodies using rapid HIV-1 diagnostic test kits
(Abbott, Belgium) with a sensitivity of 99.9% and specifi-
city of 98% following the manufacturers’ instructions.
The results were interpreted following the current
national algorithm for screening of HIV-1 infection [29].
CD4 cells count was not measured and none of the
study subjects was on antiretroviral therapy because of
lack of access in the setting during the study period. Pre
a n dp o s tH I Vt e s tc o u n s e l l i n gw a sp r o v i d e dt op a t i e n t s
and controls as per the routine program.
Biochemical analysis
Serum level of retinol (vitamin A), albumin, total protein
and total cholesterol were determined following stan-
dard procedures and briefed as follows:
Serum vitamin A: Serum retinol was determined using
high performance liquid chromatography (HPLC)
according to the method of Arroyave et al [30] utilizing
a Shiseido HPLC system (Shiseido Co. Ltd., Tokyo,
Japan) which consisted of a separation by a reverse
phase column (Capcell Pak C18 MG S-5, 3 × 250 mm,
5 μm, Shiseido, Japan) and ultraviolet detection using
methanol as a mobile phase system. The flow rate was
adjusted at 500 μl/min with column temperature set at
40°C. Serum was deproteinised with an alcoholic solu-
tion of retinyl acetate and extracted into hexane. The
organic layer was separated, evaporated to dryness
under a steam of nitrogen, reconstituted in methanol
and injected into the HPLC system with a detection
wave length set at 325 nm. All extraction procedures
were carried out under reduced light in order to prevent
oxidation of the compounds. Pooled human sera were
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iation in laboratory analyses for serum retinol and found
to be 6.5% and 3.3%, respectively. VAD was defined as
serum retinol level below <0.7 μmol/l or 20 mg/dl [1].
Serum albumin
Serum albumin was determined by end point colori-
metric assay in which at pH value of 4.2 albumin display
a sufficiently cationic character to be able to bind with
bromcresol green (BCG), an anionic dyestuff, to form a
blue green complex. The intensity of the blue green col-
our is directly proportional to the concentration of albu-
min and was determined photometrically (AUTOLAB
PM 4000/3, Analyser Medical System, Italy). The analy-
tical sensitivity (lower detection limit) of the assay
which represents the lowest measurable albumin con-
centration that can be distinguished from zero is 0.2 g/
dl or 2 gm/l. Hypoalbuminemia was defined as serum
albumin level below 3.5 gm/dl or 35 gm/l [31].
Total Protein
Total serum protein (TSP) was determined by enzymatic
reaction sequence in which protein in serum forms a
blue coloured complex when reacted with cupric ions in
an alkaline solution (Teco Diagnostics, USA). The inten-
sity of the violet colour was proportional to the amount
of protein present when compared to a solution with
known protein concentration and was determined
photometrically (AUTOLAB PM 4000/3, Analyser Med-
ical System, Italy). Hypoproteinemia was defined as
serum protein level below 6.2 gm/dl or 62 gm/l [31].
Total Cholesterol
Total cholesterol was determined by enzymatic colori-
metric test using cholesterol esterase and cholesterol
oxidase. Briefly, cholesterol was converted to cholest-4-
en 3-one and hydrogen peroxide by oxygen with the aid
of cholesterol esterase. The produced hydrogen peroxide
under the catalytic action of peroxidise formed a red
dyestuff when reacted with 4- aminoantipyrine and phe-
nol (Biocon Diagnostic, Germany). The colour intensity
was directly proportional to the concentration of choles-
terol and was determined photometrically (AUTOLAB
PM 4000/3, Analyser Medical System, Italy). The analy-
tical sensitivity (lower detection limit) of the assay
which represents the lowest measurable cholesterol con-
centration that can be distinguished from zero was mg/
dl (0.08 mmol/Lt). Hypocholesterolemia was defined as
serum level below 154 mg/dl [31]. Cholesterol level of
below 200 mg/dl was considered as indicator for the
absence of lipid metabolic disturbance and cholesterol
level of 200-300 mg/dl with HDL cholesterol below 35
mg/dl and above 300 mg/dl is considered as indicator
for the presence of lipid metabolic disturbance.
Quality control
In all cases commercially available control materials
with established values were used for quality control
purpose and no failure was observed to obtain the
assigned values. In addition, pooled sera were used to
measure intra and inter-assay coefficients of variation in
laboratory analyses for serum retinol and found to be
less than 5%. Sufficient sera for the determination of
albumin, protein and cholesterol were only found for
the 107 pregnant women. And also it was not possible
to find extra sera in the control group.
Data analysis
Data were analyzed using SPSS version 17 statistical
package (SPSS, Inc., Chicago, IL, USA). The significance
of differences in the serum vitamin A, total protein,
albumin and total cholesterol levels between pregnant
women with or without HIV infection and healthy con-
trols was evaluated using a one way analysis of variance
with post hoc Tukey test to determine pairs of means
which differ significantly. In all cases a P value of < 0.05
was considered statistically significant.
Results
A total of 423 pregnant women were included in this
study. Among the 423 pregnant women, 44 (10.4%)
were infected with HIV. From the total of 55 non
pregnant voluntaries blood donors, who were living in
the same geographic locale with the pregnant women,
30 (54.5%) were found to be HIV positive. The mean
age of pregnant and the non pregnant women was
25.38 ± 5.68 (range 16-45 years) and 28.07 ± 7.2
(range 18-41 years), respectively. The mean age of
pregnant women with and without HIV infection was
25.50 ± 4.90 (range 18-42 years) and 25.37 ± 5.76
(range 16-45 years), respectively. Whereas mean age of
asymptomatic HIV positive healthy non pregnant
women and healthy HIV negative controls was 29.57 ±
6.77 (range 18-38 years) and 26.28 ± 5.9 (range 18-41
years), respectively, with no significant difference in
age distributions (Pv a l u e>0.05).
Table 1 shows the concentrations of serum retinol in
pregnant women and non pregnant controls. After con-
trolling for total serum protein, albumin and demo-
graphic variables, the mean ± SD serum vitamin A in
HIV seropositive pregnant women (0.96 ± 0.42 μmol/L)
was significantly lower than that in pregnant women
without HIV infection (1.10 ± 0.45 μmol/L, P < 0.05). A
significant interaction between HIV positive group and
level of TSP was observed. To further explore this inter-
action, we compared the mean retinol concentrations of
those with a high TSP and those with hypoproteinemia
by HIV status. The mean retinol concentration was sig-
nificantly lower in the HIV positive pregnant women
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ent from that of HIV negative group.
The mean concentration of serum vitamin A was not
significantly different between HIV positive pregnant
women and HIV positive non pregnant women. It was
also not significantly different between HIV negative
pregnant women and HIV negative apparently health
non pregnant controls. However, mean concentration of
serum vitamin A level was significantly higher in HIV
positive pregnant women (0.96+/-0.42) than that in HIV
positive non pregnant women (0.74+/-0.39) (P = 0.02).
Irrespective of pregnancy, HIV positive women had sig-
nificantly lower serum concentration of vitamin A com-
pared with HIV negative women (P < 0.05). Non
pregnant women without HIV infection had significantly
higher serum vitamin A concentration compared to non
pregnant controls with HIV infection, P < 0.001. The
mean serum vitamin A level of HIV positive pregnant
women was 0.96 ± 0.42 where as the mean serum vita-
min A level of HIV negative pregnant mothers was 1.1 ±
0.45. This mean difference in serum vitamin A level
between the groups was statistically significant (P = 0.01).
Of the total 478 pregnant and non pregnant women
(including controls), VAD was observed in 99 (20.7%)
with a serum retinol level of less than 0.7 μmol/L (Table
2). The proportion of HIV positive pregnant women
with serum retinol levels consistent with severe (0.00-
0.34 μmol/L) and moderate (0.35-0.69 μmol/L) VAD
was significantly higher than that in healthy controls
(without HIV infection) and asymptomatic HIV infected
controls (p< 0.05). From the total 74 HIV positive
women, 33.8% (25/74) had a retinol level of less than
0.7 μmol/L and were vitamin A deficient.
Of 423 pregnant women, VAD was observed in 78
which accounted for 18.4% prevalence rate of VAD
among pregnant women. Out of the 44 pregnant
women with HIV infection, 11 (25%) were deficient for
vitamin A with serum retinol level of below 0.7 μmol/L
of which, 3 (6.8%) and 8 (18.2) had moderate (0.35-0.69
μmol/L) and severe (0.00-0.34 μmol/L) vitamin A defi-
ciency, respectively. Similarly, among 30 asymptomatic
HIV infected non pregnant voluntaries, 46.7% (14/30)
were vitamin A deficient with serum retinol level of
below 0.7 μmol/L, of which, 4 (13.3%) and 10 (33.3%)
had moderate (0.35-0.69 μmol/L) and severe (0.00-0.34
μmol/L) vitamin A deficiency, respectively.
As indicated in Table 1 and 3, serum albumin and
cholesterol concentrations were significantly lower in
the HIV positive pregnant women compared with HIV
negative pregnant women (P < 0.001). There was no sig-
nificant difference in TSP value within the two groups
(P = 0.06). Although the mean serum levels of vitamin
A decreases with age, the difference between was not
statistical significance (P = 0.07) (Table 4). Mean serum
vitamin A level was significantly lower among women
with BMI < 18.5 kg/m
2 than among those with BMI of
18.5 kg/m
2 or above, P value = 0.024 (Table 4).
Although, BMI is not a surrogate for nutritional assess-
ment during pregnancy, undernourished (BMI < 18.5
kg/m
2) was observed in 4% of the pregnant women.
Body weight and BMI were significantly lower in HIV
infected pregnant woman compared to HIV non
infected pregnant woman (P < 0.05). Undernourished
(BMI < 18.5 kg/m
2) was observed in 50% of asympto-
matic HIV positive non pregnant woman (data not
shown).
Table 1 Socio-demographic characteristics and serum parameters of pregnant and non pregnant women
Characteristics Pregnant (n = 423) Non pregnant (n = 55)
With HIV (44) Without HIV (379) With HIV (30) Without HIV (25)
Age (years) 25.50 ± 4.90 25.37 ± 5.76 29.57 ± 6.7 26.28 ± 7.4
BMI (kg/m
2) 23.56 ± 3.04
¶ 23.45 ± 3.05
¶ 18.67 ± 4.31 20.55 ± 3.1
Serum retinol (μmol/L) 0.96 ± 0.42* 1.10 ± 0.45
$ 0.74 ± 0.39
§ 1.18 ± 0.59
£Albumin gm/dl 3.65 ± 0.68* 3.99 ± 85 ND ND
£Total protein (gm/dl) 6.12 ± 0.94 5.99 ± 1.22 ND ND
£Cholesterol (mg/dl) 144.5 ± 54.20* 168 ± 51.52 ND ND
Keys: ¶P value <0.001 versus HIV positive non pregnant women and HIV negative non pregnant women; *P value = 0.04 versus HIV negative pregnant women,
$P value = 0.02 versus HIV positive non pregnant women,
§ P value = 0.000 verse HIV negative non pregnant women, ND: Not done, £ N = 107
Table 2 Vitamin A deficiency in pregnant and non pregnant women by HIV serostatus
Vitamin A Status Pregnant women Non pregnant women
HIV +ve HIV -ve OR (95%CI) P value HIV +ve HIV -ve OR (95%CI) P value
VAD 11 (25) 67(17.7) 2.50(1.38-4.60) 0.002 14(46.7) 7(28)
Non VAD 33 (75) 312(82.3) 1.30(1.14-1.50) 0.003 16(53.3) 18(72)
Keys: +ve: Positive; -ve: Negative
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This cross-sectional study is the first of its kind in
Ethiopian pregnant mothers with and without HIV
infection in which serum levels of vitamin A has been
measured. In this study, we found biochemical evidence
that VAD was common in pregnant women, regardless
o fH I Vs t a t u si nN o r t h w e s tE t h i o p i a .V A Dh a sb e e n
defined as a public health problem when the prevalence
of VAD, judged by serum retinol less than 0.7 μmol/l,
among pregnant women is 15% [32]. In the present
study, the overall prevalence of VAD among pregnant
and non pregnant women was 18.4%, thus indicating a
marginally major public health problem but neglected
among these pregnant women in tropical settings of
Northwest Ethiopia.
Due to multiple guidelines and lack of precise recom-
mendation, nutritional surveys have used diverse reference
values as a cut off indicating deficient vitamin A status.
This in turn has jeopardized comparability of results of
population-based prevalence studies. Although interna-
tional consensus has yet to be establishes, serum retinol
concentration below a cutoff of 1.05 μmol/l has been pro-
posed to reflect low vitamin A status among pregnant and
lactating women [21]. While the distribution of serum
retinol concentrations below appropriate cut-offs are con-
sidered to reflect inadequate states of vitamin A nutriture,
a low biochemical concentration of retinol in circulation is
not considered a VAD. Thus, it is difficult to compare
rates of VAD among previous studies. Even with this lim-
itation, the 18.4% prevalence of VAD in this study popula-
tion of pregnant women is a lower rate compared with
previous report in a settings where about 40% rate of VAD
has been reported [33] and previous reports from Bangla-
desh where VAD as high as 69% had been reported
[34,35]. However, it is in agreement with a South African
study which showed 16% VAD among mothers during the
first 6 months of delivery [36]. The high rate of VAD in
our study group could be due to dietary factors including
inadequate vitamin A intake in Ethiopian population [24]
and the relatively poor socio-economic and nutritional sta-
tus of Ethiopian mothers compared with mothers in some
other parts of developing nations.
This study showed that, HIV positive pregnant women
had significantly lower mean serum retinol concentra-
tion than did HIV negative pregnant women (P<0.05).
This finding was consistent with a study from Malawi
[37], Rwanda [38,39] and Zimbabwe [40]. The low levels
of serum vitamin A might be due to a low release of
vitamin A from the liver during HIV infection, which
would lead to low levels of vitamin A in the plasma
despite the body having enough vitamin A liver stores
[16]. The mean serum vitamin A level of HIV seroposi-
tive pregnant women was 0.96 ± 0.42 where as the level
in HIV negative pregnant mother was 1.1 ± 0.45 (P
value <0.001). This significant difference in serum vita-
min A between HIV positive and negative pregnant
women remained after measures of total serum protein,
albumin and demographic variables (age, weight, BMI)
were controlled for, which was also in agreement with a
Zimbabwean study [40]. Low serum vitamin A level
among HIV infected pregnant women was reported to
be associated with a higher risk of vertical transmission
Table 3 Prevalence of micronutrient deficiencies and distribution of pregnant women and controls by HIV infection
and serum status of micronutrients
Parameters Cutoff
value
HIV positive
pregnant women
(44)
HIV negative
pregnant women
(379)
HIV positive
non pregnant women
(30)
HIV negative non
pregnant controls
(25)
Deficient Non
deficient
Deficient Non
deficient
Deficient Non
deficient
Deficient Non
deficient
Vitamin A 0.7 μmol/L 33 (75)*
0.79 ± 0.32**
11(25)
1.45 ± 0.25
234 (61.7)
0.82 ± (0.26)
$
145 (31.8)
1.54 ± (0.29)
26(86.7)
0.63 ± 0.28)
4(13.3)
1.45 ± (0.16)
12(48)
0.68 ± (0.27)
13(52)
1.6 ± (0.39)
TSP
(107)
6.2 gm/dl 8/13(61)
5.6 ± (0.68)
5/13(39)
7.1 ± (0.35)
56/94(59)
5.2 ± (0.55)
38/94(41)
7.2 ± (0.85)
ND ND ND ND
Albumin (107) 3.5 gm/dl 6/33 (18)
3.06 ± (0.39)
27/33(82)
3.04 ± (0.51)
7/74(9)
4.15 ± (0.39)
67/72(91)
4.3 ± (0.64)
ND ND ND ND
Cholesterol
(107)
154 mg/dl 9/13(69
119.8 ± (28)
4/13(31)
200.5 ± (59)
38/94(40)
119.5 ± (20.8)
56/94(60)
200.8 ± (38)
ND ND ND ND
Keys: *Number (%), ** Mean ± SD,
$P value< 0.05 versus HIV negative non pregnant controls, ND: Not done
Table 4 Relationship between serum vitamin A level with
age and body mass index (BMI)
Variables N Serum retinol (μmol/L)
Mean ± SD
P value
Age (Years)
< 20 20 1.09+0.44 0.070
21-30 274 1.06+0.45
31-40 73 1.04+0.48
41+ 4 0.88+0.57
BMI (kg/m
2)
<18.5 34 0.89 ± 0.43 0.024
>18.5 444 1.08 ± 0.45
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maternal anaemia [41].
HIV positive women had significantly lower serum
concentration of vitamin A compared with HIV negative
women (P < 0.01), irrespective of pregnancy. Serum reti-
nol may transiently be low due to reduced production of
retinol binding protein, which is often observed as part
of the acute-phase response to infection [42]. Further-
more, it is also important to note that sub-clinical infec-
tion or inflammation has been found to be associated
with the reduction of serum retinol level due to reduced
production of retinol binding protein [42]. Although, we
do not have any indication on the presence of sub-clini-
cal infection on our study group and we did not mea-
sure acute inflammatory responses in the present study.
It should be noted that, times of blood collections for
all pregnant women was their routine antenatal follow
up and all participants were healthy. Other possible con-
founding factors such as intestinal helminths [42,43]
may influence serum retinol concentrations as high pre-
valence of helminthic infection was reported in the
study area [26,27,43]. Low intake of green vegetables,
fruit and dairy products could also be contributing fac-
tors for the low serum vitamin A level, as the staple
food in Northwest Ethiopian is mainly a pancake named
enjera made from a cereal called Tef (Eragrostis teff).
Usually the enjera is eaten with stew made from
legumes (mainly pea and beans).
In this study, overall prevalence of hypoalbuminaemia
in pregnant women was relatively low (12%). This find-
ing is similar to that of an earlier study carried out
among Ethiopian pregnant mothers in the same locality
[25]. No significant interaction between HIV sero-posi-
tive status during pregnancy and level of TSP was
observed among vitamin A deficient women suggesting
the lack of contribution of general protein-energy
undernourished to VAD. In the present study, under-
nourished (BMI <18.5 kg/m
2)w o m e nw e r ef o u n dt o
have statistically significantly lower serum retinol level
than well-nourished (BMI > 18.5 kg/m
2) women. This is
consistent with other studies from Bangladesh and
Nepal [9,35].
Conclusions
The present study shows that VAD among pregnant
women in tropical settings of northwest Ethiopia is a
major public health problem. Irrespective of pregnancy,
HIV positive women had significantly lower serum con-
centration of vitamin A levels compared with HIV nega-
tive women. Considering the possible implications of
VAD during pregnancy, we recommend multivitamin
(which has a lower level of vitamin A) supplementation
in the care and management of pregnant women with
or without HIV infection.
Limitations
This study has the following basic limitations. First, due
to the presence of multiple guidelines and lack of pre-
cise recommendation, nutritional surveys have used
diverse reference values as a cut off between normal and
deficient vitamin A status. As a result, VAD in this
study was defined based on WHO recommendation
which are wildly accepted and used [1], as serum retinol
level below 0.7 μmol/L. Second, micronutrient status is
difficult to assess in the presence of infection, because
biochemical indicators of several micronutrients are
affected by the acute phase response. For instance, albu-
min, and retinol are “negative” responders, which
increase during an acute phase response markers [36].
Thus, since in the present study, acute phase response
(for example, C-reactive protein (CRP) and alpha 1- acid
glycoprotein (AGP)) were not measured and controlled.
Such markers were not measured in these subjects, due
to the lack of laboratory facility. Hence, the results may
be confounded by increased rates of acute phase
response measures in the HIV positive women and may
lead to an underestimation of vitamin A and albumin
status. Third, body mass index (BMI) was used to deter-
mine the nutritional status of the study subjects though
it is not a surrogate for nutritional assessment during
pregnancy. Lastly, the low number of sample size
among the control group resulted inflated HIV preva-
lence and hence might influence the results.
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